CN Patent

CN106580903B — 罗红霉素缓释药物组合物

Assigned to Jiangsu Hansoh Pharmaceutical Group Co Ltd · Expires 2019-12-13 · 6y expired

What this patent protects

本发明涉及一种罗红霉素缓释药物组合物，含有至少有效治疗剂量的罗红霉素、水溶性高分子物质、水不溶性高分子物质、糖类、二氧化钛。该药物组合物对光照、高温、高湿等条件比较稳定，具有缓释效果。本发明的罗红霉素缓释药物组合物的制备工艺简单，适合工业化生产。

USPTO Abstract

本发明涉及一种罗红霉素缓释药物组合物，含有至少有效治疗剂量的罗红霉素、水溶性高分子物质、水不溶性高分子物质、糖类、二氧化钛。该药物组合物对光照、高温、高湿等条件比较稳定，具有缓释效果。本发明的罗红霉素缓释药物组合物的制备工艺简单，适合工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN106580903B
Jurisdiction
CN
Classification
—
Expires
2019-12-13
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Hansoh Pharmaceutical Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.